340 likes | 577 Views
HPI: 29 year-old G6P4014 admitted for preeclampsia and thrombocytopenia. Induction on HD
E N D
1. Interesting Case October 18, 2005
10. Night of 10/13/05:
upper GI bleeding with coffee-ground emesis
patient became hypotensive, then stabilized with NS volume resuscitation
Hb dropped from 10.6 to 9
Patient suddenly became hypotensive and pulseless
aggressive resuscitation unsuccessful
Cause of death: GI bleed, possible cardiac tamponade 2o to TTP
17. Thrombotic thrombocytopenic purpura
20. Thrombotic thrombocytopenic purpuraDemographics Incidence: 1:100,000 - 1:500,000
Male:female 1:2
Age
Most common in 30-40 year olds
90% of patients = 60 years old
No racial differences
No seasonal difference
21. Clinical Findings in TTP Microvascular thrombi: MAHA
Normal coagulation
Thrombocytopenia (< 20,000/µl)
Anemia < 10g/dl
Reticulocytosis
£ LDH
£ Indirect bilirbuin
¤Haptoglobin
Pentad of symptoms
22. Pentad of TTP
23. Alternative diagnoses of patients who have clinically suspected TTP/HUS Apparent after the plasma exchange has begun
Autoimmune disorders
Systemic lupus erythematosus
Scleroderma
Anti-phospholipid antibody syndrome
Sepsis
Malignant hypertension
Heparin-induced thrombocytopenia/thrombosis
Disseminated malignancy
24. Presentations of TTP/HUSThrombotic microangiopathy Idiopathic
No apparent etiology or associated condition
Drug-induced
Allergic: Quinine, ticlopidine
Dose-related: Mitomycin, gemcitabine, cyclosporin
Pregnancy/postpartum
Diarrhea-associated
Bone marrow transplantation
Congenital
25. TTP in pregnancy (1) GI complaints often initial sign
(2) preeclampsia (hypertension) often present
(3) most common at term with progression post-partum
(4) severe neurologic abnormalities and renal failure
(5) disseminated microvascular thrombosis in absence of plasma exchange
26. TTP in Pregnancy risk increases near term and post-partum
accounts for 10% of all TTP
decreased ADAMTS-13 activity and increased plasma vWF in 2nd / 3rd trimesters
difficult to distinguish TTP / HELLP syndrome
29. vWF Multimers
Made in megakaryocytes and endothelial cells
Stored in platelet alpha granules and Weibel-Palade bodies of endothelial cells
Ultralarge molecule cleaved to smaller subunits by protease ADAMTS-13
ULVWF : highly adhesive to platelets
30. vWF, Proteolysis, and Platelet Adhesion
31. von Willebrand Factor Multimers
33. Treatment Plasma exchange
removes antibody
restores ADAMTS-13
improves mortality rate to 10 20%
daily for 1-2 weeks
Hemodialysis if kidney fails
Plasma infusion if exchange not available
Corticosteroids for non-responders
34. Summary Lab diagnosis of TTP:
Thrombocytopenia
Microangiopathic anemia:
Schistocytes
Increased LDH due to tissue necrosis
Rule out other causes of MAHA
Treatment: Urgent plasma exchange